Interactions between ovarian cancer cells and the surrounding tumor microenvironment are not well characterized. We have earlier shown that ovarian cancer ascites induces Akt activation and protect tumor cells from TRAIL-induced apoptosis. Here, we investigated the mechanism by which ascites activates Akt. The ability of ovarian cancer ascites to activate Akt and inhibit TRAILinduced cell death and caspase activity was decreased by heat inactivation, but was retained in ascites fractions 45 kDa. The survival promoting activity of ascites was not affected by inhibitors of growth factor receptor including epidermal growth factor receptor (EGFR), VEGFR, FGFR, Her2/neu, and IGF-R1. However, this activity was inhibited by an avb5 integrin-blocking antibody, but not by blocking antibodies against avb3, b1, or b3 integrins. avb5 integrin-blocking antibodies also inhibited ascites-induced Akt phosphorylation and c-FLIPs up-regulation. Ovarian cancer ascites induced a rapid phosphorylation of focal adhesion kinase (FAK), which closely correlated with the phosphorylation of Akt overtime. FAK phosphorylation was strongly inhibited by avb5 integrin-blocking antibodies. Depletion of FAK content by RNA interference was also associated with inhibition of ascites-mediated Akt activation and survival. These results suggest that ovarian cancer ascites induces FAK and Akt activation in an avb5 integrin-dependent pathway, which confers protection from TRAIL-induced cell death and caspase activation.
Introduction
Epithelial ovarian cancer (EOC) is associated with a poor prognosis because most cancers are detected at a late stage. EOC is a highly metastatic cancer characterized by widespread intraperitoneal dissemination and ascites formation (Puls et al., 1996; Shen-Gunther and Mannel, 2002) . EOC ascites may contain a variety of cytokines, growth factors, bioactive lipids, hormones, and components of the extracellular matrix. Ascites promotes migration (Yamada et al., 2004; Ren et al., 2006) and invasion of EOC cells (Graves et al., 2004; Puiffe et al., 2007) . The impact of ascites on tumor cell survival has been best described by recent observations showing that ascites obtained from women with advanced EOC inhibited death receptor-induced apoptosis (Lane et al., 2007) . In this study, the survival promoting activity of ascites was mostly dependent on activation of the Akt pathway. However, the mechanism by which ascites activated Akt was not defined. Tumor cells in ovarian cancer effusions have also been characterized by higher expression of Akt compared with cells present in benign effusions (Davidson et al., 2006) reinforcing the idea that ascites contains factors that activate the Akt pathway. Activation of the Akt pathway by EOC ascites also suggests that ascites factors may engage cell surface receptors capable of activating Akt. Identifying the factors and the cell surface receptors involved in promoting tumor cell survival will not only improve our understanding of the disease, but will hopefully enable us to identify a number of novel marker for drug response and patient survival.
Activation of a number of cell surface receptors may contribute to activation of the Akt pathway in human tumors. The binding of growth factors to tyrosine kinase receptors stimulates the phosphorylation of phosphatidylinositol 3-kinase (PI3K), which in turn leads to Akt activation. Epidermal growth factor receptor (EGFR), platelet-derived growth factor receptor, and Her2/neu are commonly overexpressed in EOC and are involved in the control of tumor cell proliferation and apoptosis, and seem to have a central function in the progression of ovarian cancer (Kohler et al., 1989 (Kohler et al., , 1992 Alper et al., 2001; Matei et al., 2006) . These tyrosine kinase receptors exert many of their biological activities through the activation of the PI3K/Akt pathway (Stoica et al., 2000; Yarden and Sliwkowski, 2001) . Several studies have recently indicated that alterations in PI3K/Akt-signal transduction pathways can modulate sensitivity to cancer chemotherapy in ovarian cancer (Fraser et al., 2003; Dan et al., 2004; Yang et al., 2006) . Ovarian cancer ascites contains growth factors that could potentially activate tyrosine kinase receptor, thereby promoting cell survival (Saltzman et al., 1999; Abendstein et al., 2000; Miyamoto et al., 2004) . PI3K may also become activated through G-protein-coupled receptors. G-protein-coupled receptors regulate a variety of cell functions including cell proliferation, survival, and motility, and have recently emerged as important players in tumor growth and survival (Mills and Moolenaar, 2003) . One of the ligands of G-proteincoupled receptors, the lysophosphatidic acid (LPA), has been shown to induce cell survival signaling through the PI3K/Akt pathway in ovarian cancer cells (Kang et al., 2004) . LPA may bind to four distinct receptors LPA1-4. Among these receptors, LPA2, LPA3, and LPA4 are aberrantly expressed in ovarian cancer cells (Goetzl et al., 1999) . LPA receptors can couple to at least three distinct G proteins (G q , G i , and G 12/13 ). Activation of the PI3K/Akt pathway has been predominantly linked to the activation of G i by LPA. Ascites fluid contains significant levels of LPA, which exceed levels required to activate LPA receptors (Yamada et al., 2004) . The ability of LPA to stimulate the PI3K/Akt pathway in ovarian cancer cells and the recent demonstration that ascites induces Akt phosphorylation (Lane et al., 2007) raises the possibility that growth factors and/or bioactive lipids may contribute to the ascites prosurvival effect. Akt may also become activated by the interactions between extracellular matrix proteins with cell surface integrins, a family of heterodimers of a and b subunits (Hynes, 1992) . Different integrins exhibit different ligand specificities. Integrins transmit signals directly through ligation-dependent recruitment of the focal adhesion kinase (FAK) leading to the activation of several cell-signaling pathways including the PI3K/Akt pathway (Stupack and Cheresh, 2002) . The function of integrins in mediating cell proliferation, migration, and survival in ovarian cancer is well established (Carreiras et al., 1999; Cruet-Hennequart et al., 2003; Lane et al., 2008) .
Although ascites stimulated the Akt pathway (Lane et al., 2007) , the mechanisms of activation have not been defined. The purpose of our study was to investigate how the Akt pathway is activated by ascites. In search of cell surface receptors capable of signaling through Akt, we observed that the selective blockade of avb5 integrin markedly decreased ascites-induced Akt phosphorylation. In addition, ascites induced a rapid FAK phosphorylation, and the blockade of avb5 integrin abolished ascites-induced FAK phosphorylation. Collectively, these data show that ovarian cancer ascites activates Akt and promotes protection from TRAILinduced cell death through an avb5 integrin-dependentsignaling pathway.
Results
Heat-sensitive factors contribute to the survival promoting activity of EOC ascites Earlier results from our laboratory showed that EOC ascites confers protection to death receptor-induced apoptosis through activation of the PI3K/Akt pathway (Lane et al., 2007) . To assess whether the survival promoting activity of ascites could be mediated by protein-based constituents, three different ascites (COV10, OVC346, and OVC508) were heat inactivated by treatment at 95 1C for 15 min. CaOV3 cells were preincubated with these ascites (10% v/v) for 1 h and treated with TRAIL. Under these conditions, the protective activity of ascites against TRAIL-induced cell death was decreased by X50% (Figure 1a) . We also determined whether heat-inactivation affects Akt phosphorylation. As shown in Figure 1b , ascites heat inactivation consistently inhibited the Akt phosphorylation. We tried to confirm the protein nature of the ascites factors by pre-incubating ascites with trypsine and proteinase K. However, TRAIL was inactivated by the proteases, and we could not confirm the protein nature of the survival factors.
We also examined the ability of heat-inactivated ascites to prevent caspase-8 and caspase-3 activation in the presence of TRAIL. We observed a significant decrease of TRAIL-induced caspase-8 and caspase-3 activation in the presence of non-inactivated COV10, OVC346, and OVC508 ascites (Figure 1c ). However, heat treatment almost completely abrogated the ability of these ascites to inhibit TRAIL-induced caspase-8 and caspase-3 activation. These data were confirmed by immunoblot as shown by the near complete disappearance of procaspase-8 and the appearance of p18 actives fragments, and by the disappearance of procaspase-3 in the presence of heat-inactivated ascites (Figure 1d ). In contrast, noninactivated ascites inhibited caspase-8 and caspase-3 activation. These results show that heat-sensitive factors are involved in the survival promoting activity of ascites.
Ascites survival promoting factors are mainly found in the high-molecular weight fractions The OVC346 and OVC508 ascitic fluids were centrifuged and filtered through a membrane with a 5 kDa cutoff size. CaOV3 cells were pre-incubated with the different ascites fractions for 1 h and cells were treated with TRAIL for 48 h. As shown in Figure 2a , X80% of the survival promoting activity of OVC346 and OVC508 ascites was found in the 45 kDa fractions. The prosurvival activity was completely lost in the o5 kDa fractions. Loss of activity in the o5 kDa fractions correlated with the loss of ascites ability to phosphorylate Akt (Figure 2b) . A Coomasie blue stained protein gel did not reveal protein 45 kDa in o5 kDa fraction (Supplementary Figure 1a) . In addition, 93-95% of the LPA present in OVC346 and OVC508 ascites was recovered in o5 kDa fraction as shown by ELISA (Supplementary Figure 1b) . We observed greater inhibition of TRAIL-induced caspase-8 and caspase-3 activation in ascites fractions 45 kDa (Figure 2c ). These results show that the majority of the survival promoting activity in ascites is mediated by molecules with a molecular weight 45 kDa.
Effect of growth factor receptor inhibitors on the survival promoting activity of EOC ascites As the survival promoting activity of ascites likely involves protein-based constituents and Akt has an Figure 1 Heat treatment inhibits the protective effect of ascites against TRAIL-induced cell death. (a) CaOV3 cells were preincubated for 1 h with COV10, OVC346, or OVC508 ovarian cancer ascites (10% v/v) that were either inactivated or not by heat and treated with TRAIL (10 ng/ml) for 48 h. Data are shown as the percent cell viability relative to untreated cells. The results are from three independent experiments performed in triplicate and express as mean ± s.e.m. (b) Immunoblot analysis of CaOV3 cells incubated with ascites or heat-inactivated ascites. Western blots were probed with anti-phospho-Akt (p-Akt) (Ser 473) and control anti-Akt antibody. The ratio between phosphorylated and total Akt was determined by densitometry from three independent experiments and results are presented as fold-increase relative to CaOV3 cells without ascites. Representative results from three independent experiments. (c) Caspase-8 and caspase-3 activity in CaOV3 cells incubated without ascites, with ascites, or with heat-inactivated ascites in the presence of TRAIL (10 ng/ml) for 24 h. The results are from three independent experiments performed in triplicate and expressed as mean ± s.e.m. Asterisk indicates Po0.001. (d) Immunoblot analysis of caspase-8 and caspase-3 activation demonstrating the effects of heat-inactivation on the protective activity of ascites. CaOV3 cells were pre-incubated for 1 h with COV10, OVC346 or OVC508 ascites that were either inactivated or not by heat and treated with TRAIL (10 ng/ml) for 24 h.
Ascites stimulates avb5 integrin signaling D Lane et al essential function in this survival promoting activity (Lane et al., 2007) , we explored pathways capable of activating Akt through protein-based ligands. Among others, the binding of epidermal growth factor to its receptor EGFR, stimulates Akt phosphorylation. In addition, the EGFR-signaling pathway is often activated in ovarian cancer cells (Kohler et al., 1989 (Kohler et al., , 1992 . To assess the function of EGFR in ascitesinduced protection against TRAIL, we incubated CaOV3 cells with different ascites and examined the effect of these ascites on EGFR activation. Although levels of EGFR phosphorylation induced by different ascites varied, all ascites tested consistently increased its phosphorylation ( Figure 3a) . Next, we determined whether ascites-induced Akt activation was dependent on EGFR activation. CaOV3 cells were incubated with ascites in the presence or absence of EGFR inhibitors PD153085 and AG1478. We first established a doseresponse curve for these inhibitors (data not shown) and selected the concentration, which showed potent EGFR inhibition with minimal intrinsic toxicity for further experiments. In the absence of EGFR inhibitors, ascites induced EGFR and Akt phosphorylation ( Figure 3b ). However, although ascites-induced EGFR activation was completely blocked by EGFR inhibitors PD153085 and AG1478, ascites-induced Akt activation remained unaffected by these inhibitors.
To further evaluate the involvement of EGFR in the prosurvival activity of ascites, we assessed the effects of EGFR inhibitors on TRAIL-induced cell death and caspases activation in the presence or absence of ascites. As shown in Figure 3c , EGFR inhibitors slightly increased cell viability in the presence of TRAIL. As expected, ascites substantially increased cell viability in CaOV3 cells treated with TRAIL. Incubation of EGFR inhibitors with ascites did not decrease cell viability in the presence of TRAIL. In fact, cell viability was increased by EGFR inhibitors and ascites co-incubation compared with ascites alone. EGFR inhibitors have been reported to have agonist effect and as such may stimulate cell proliferation. Thus, the greater cell viability induced by EGFR inhibitors likely reflects (Figure 3d ). More importantly, however, pre-treatment of CaOV3 cells with either PD153085 or AG1478 did not affect the inhibiting activity of ascites on TRAILinduced caspase-8 and caspase-3 activation. All together, these results suggest that ascites-induced Akt activation is not coupled to EGFR activation. As signalization through other growth factor receptors may also activate Akt in EOC cells, we treated CaOV3 cells with inhibitors specific for Her2/neu, FGF, IGF, and VEGF receptors, and subsequently examined the effect of these inhibitors on TRAIL-induced cell death. As shown in Figure 4a , the inhibition of Her2/ neu, FGF, IGF, and VEGF receptors had no effect on ascites-induced protection against TRAIL. Moreover, these inhibitors did not inhibit ascites-induced Akt phosphorylation (Figure 4b ). These results suggest that ascites stimulates survival and Akt activity through an Her2/neu, FGF, IGF, and VEGF receptor-independent pathway.
Involvement of avb5 integrin in the prosurvival effect of EOC ascites Recent data showed that avb3 and avb5 integrins ligation may activate Akt in EOC cells (Cruet-Hennequart et al., 2003) . Thus, to determine whether integrins are involved in the survival promoting activity of ascites, CaOV3 cells were treated with avb3, avb5 integrinblocking antibodies, or a control IgG antibody, and The ratio of phosphorylated EGFR to total EGFR was determined by densitometric quantification and is represented as fold-increase relative to cells without ascites. (b) CaOV3 cells were incubated with COV10 ascites in the presence or absence of EGFR inhibitors AG1478 (2.5 mM) and PD153085 (5 mM) (added 30 min before) and western blots of cell extracts were probed with anti-phospho-EGFR and -Akt, anti-EGFR, and anti-Akt. (c, d) CaOV3 cells were incubated in the presence or absence of EGFR inhibitors for 30 min and ascites was added for 1 h. Cell viability was determined by XTT assay 48 h after the addition of TRAIL. Caspase-8 and caspase-3 were determined 24 h after adding TRAIL. The results are from three independent experiments performed in triplicate and express as mean ± s.e.m.
Ascites stimulates avb5 integrin signaling D Lane et al TRAIL-induced cell death was assessed. Both avb3 and avb5 integrins are expressed by CaOV3 cells, and their levels remained unchanged in response to ascites (Table 1) . Pre-incubation of CaOV3 cells with avb5 integrin-blocking antibody reduced by approximately 50% the protective effect of ascites on TRAIL-induced cell death, whereas control IgG or avb3 integrinblocking antibodies had no effect (Figure 5a ). Furthermore, the TRAIL-induced cell death in CaOV3 cells was increased in a dose-dependent manner by avb5 integrinblocking antibody (Figure 5b ). The maximal inhibition (50%) was achieved with antibody concentrations of 5 mg/ml. To further examine the function of integrins in ascites-mediated protection from TRAIL, CaOV3 cells were incubated in the presence of antibodies that specifically block av, b1, or b3 subunits. Despite the fact that b1 and b3 subunits were expressed in CaOV3 cells (Table 1) , anti-b1-and anti-b3-blocking antibodies did not affect the protective effect of ascites against TRAIL (Figure 5c ). Anti-av antibodies had a limited (approximately 10% inhibition) effect on ascites-induced protection. The effect of avb5 integrin-blocking antibodies was assessed in a primary culture of EOC derived from ascites (318A cells). In these cells, avb5 integrin-blocking antibodies significantly (Po0.001) inhibited the protective effect of ascites (Figure 5d ). These results show that avb5 integrins are specifically involved in ascites-mediated protection of TRAILinduced cell death.
To further confirm the function of avb5 integrin, we assessed the effect of avb5 integrin-blocking antibody on TRAIL-induced caspase-8 and caspase-3 activation in CaOV3 cells in the presence or absence of ascites. The presence of ascites alone strongly inhibited TRAILinduced caspase-8 and caspase-3 activation (Figure 5e) . However, the ascites-mediated caspases inhibition was significantly reverse (Po0.001) by incubation of CaOV3 cells with avb5 integrin-blocking antibody, but not with avb3 integrin-blocking antibody.
Blockade of avb5 integrin inhibits EOC ascites-mediated Akt activation
We examined the consequence of avb5 integrin blockade on Akt activation in CaOV3 cells. The addition of avb5-blocking antibody, but not the control IgG or the avb3-blocking antibodies, strongly, but not completely, inhibited the ascites-induced Akt phosphorylation (Figure 6a ). These data show that ascites-mediated Akt activation occurs, at least partly, through the avb5 integrin-signaling pathway. As we earlier showed that caspase-8 inhibitor c-FLIPs protein expression is upregulated by Akt, we assessed whether the blockade of avb5 integrin can inhibit ascites-mediated c-FLIPs upregulation. Treatment of CaOV3 cells with avb5 integrin-blocking antibodies resulted in a reduction of c-FLIPs expression in the presence of ascites (Figure 6b ).
EOC ascites induces FAK phosphorylation in an avb5 integrin-dependent mechanism
The engagement of integrins to the extracellular matrix components triggers a signaling cascade that leads to the activation of FAK, one of the earliest events that immediately follows integrin-extracellular matrix engagement (Stupack and Cheresh, 2002) . As shown in Figure 7a and b, incubation of CaOV3 cells with ascites induces rapid (within 15 min) FAK and Akt phosphorylation that reached a peak after 90 min. Total FAK protein levels were, however, not altered by ascites. To determine whether ascites-induced FAK activation was mediated by avb5 integrin, we incubated CaOV3 cells with b1, avb3, or avb5 integrin-blocking antibodies (Figure 7c ). Adding avb5 integrin-blocking antibody completely blocked the phosphorylation of FAK, whereas FAK phosphorylation was unchanged by adding the b1 or the avb3 integrin-blocking antibody. These data indicate that FAK phosphorylation induced by EOC ascites is avb5 integrin dependent.
Knockdown of FAK inhibits ascites-mediated Akt activation and cell survival
To further examine the link between integrins, FAK, Akt, and the survival promoting activity of ascites, we depleted cellular FAK content by small-interfering RNA (siRNA). Figure 8a shows that siRNA-mediated FAK knockdown inhibited ascites-mediated Akt activation. In contrast, the control siRNA (Luc) did not affect Ascites stimulates avb5 integrin signaling D Lane et al Ascites + anti-αvβ5
IgG control Figure 5 Involvement of the avb5 integrin in the prosurvival activity of ovarian cancer ascites. (a) CaOV3 cells were incubated with avb3 or avb5 integrin-blocking antibodies (5 mg/ml), or with control IgG for 30 min before adding OVC346 ascites. After 1 h, TRAIL (10 ng/ml) was added for 48 h. Cell viability was assessed by XTT assay and expressed as the percent survival relative to untreated CaOV3 cells. The results are from three independent experiments performed in triplicate and express as mean ± s.e.m. (b) CaOV3 cells were incubated with increasing concentrations of avb5 integrin-blocking antibodies for 30 min and treated as described above.
(c) CaOV3 cells were incubated with avb3, avb5, av, b1, or b3 integrin-blocking antibodies and their impact on cell viability was determined as above. *Po0.001 versus avb3, b1, or b3 integrin-blocking antibodies. (d) The primary culture of 318A cells isolated from ascites of a patient with advanced EOC was incubated with avb3 or avb5 integrin-blocking antibodies. After 1 h, TRAIL (10 ng/ml) was added for 48 h. The results are from three independent experiments performed in triplicate and express as mean±s.e.m. (e) CaOV3 cells were incubated with avb3 or avb5 integrin-blocking antibodies (5 mg/ml) and treated as described above. Caspase-8 and caspase-3 activity was assessed after 24 h. The results are from three independent experiments performed in triplicate and express as mean ± s.e.m. *Po0.001 versus OVC346 ascites and ascites þ avb3 integrin-blocking antibodies.
Ascites stimulates avb5 integrin signaling D Lane et al the ascites-mediated phosphorylation of FAK and Akt, and did not affect FAK protein levels. On the basis of densitometric scanning of three independent experiments, FAK depletion was associated with complete inhibition of ascites-mediated Akt phosphorylation (Figure 8b ). The ascites-mediated inhibition of TRAIL-induced cell death was partially reverse by incubation of CaOV3 cells by FAK siRNA, but not with the control siRNA ( Figure 8c ). FAK depletion caused approximately 50% reduction of cell viability, which was in the same order of magnitude compared with the effect of avb5 integrin-blocking antibody. FAK depletion significantly inhibited ascites-induced protection from TRAIL-mediated apoptosis (Figure 8d ). All together, these data suggest that Akt activation through the FAK pathway significantly contributes to the protective effects of ascites.
Discussion
The ability of TRAIL to kill EOC cells is counteracted by ascites, promoting the survival of tumor cells in these fluids (Lane et al., 2007) . In this study, we showed that at least three different ascites obtained from patients with metastatic EOC contain high-molecular weight (45 kDa), heat-sensitive factors, that protect EOC cells from TRAIL-induced cell death, and caspases activation. This protection was strongly related to the ability of ascites to stimulate Akt. EOC ascites was shown to activate FAK and Akt through an avb5 integrindependent-signaling pathway. The blockade of avb5 integrin and FAK knockdown abolished approximately 50% of the prosurvival activity of ascites. Advanced EOC is characterized by widespread intraperitoneal dissemination and ascites formation. The morbidity and mortality of EOC are due to the failure of initial therapy to eradicate a sufficient number of tumor cells to prevent disease recurrence (Shen-Gunther and Mannel, 2002) . Although the function of ascites in tumor development and progression is still not well understood, ascites constitutes a microenvironment that may promote tumor cell survival and metastasis. Earlier reports showed that EOC ascites stimulates the motility, migration, proliferation, and invasion of tumor cells, which likely contribute to the metastasis process (Graves et al., 2004; Yamada et al., 2004; Ren et al., 2006; Puiffe et al., 2007) . These effects were mainly attributed to the presence of LPA that accumulates in high concentration in EOC ascites (Westermann et al., 1998) . Supporting the function of LPA is the observation that migration response of ascites was almost completely abolished by LPA1 receptor inhibitor and G i/o -protein-coupled receptor inhibitor pertussis toxin. In this context, it has been shown that EDG family receptors LPA1, LPA2, and LPA3 are coupled to the pertussis toxin-sensitive G proteins (Contos et al., 2000; Ye et al., 2002; Noguchi et al., 2003) . LPA does not seem to contribute to the prosurvival activity of ascites because LPA is relatively heat resistant (Mills et al., 1988) and it was recovered in the o5 kDa fraction of ascites, which was inefficient in protecting CaOV3 cells from TRAIL-induced cell death. Furthermore, treatment of CaOV3 cell with pertussis toxin or selective LPA3 inhibitor, DGPP, did not affect Figure 2) . These observations suggest that factors other than LPA contribute to the prosurvival activity of ascites. Growth factor receptor and integrin-signaling pathways have been shown to mediate Akt activation. EOC cells expressed different growth factor receptors including EGFR, Her2/neu, platelet-derived growth factor receptor, VEGFR, FGFR, and IGF-R1 that promote cell proliferation and/or drug resistance. With the use of chemical inhibitors, we assessed the function of these growth factor receptors and found that their inhibition had no impact on the ascites survival promoting activity. However, the integrin pathway was involved in ascites-mediated protection from TRAIL-induced apoptosis. Among the integrins tested, only avb5 integrin contributed to ascites-mediated survival and Akt phosphorylation. Thus, selective avb5 integrin ligation by ascites factor(s) activates Akt-dependent survival signals that counteract TRAIL-induced cell death in EOC cells. The ligand(s) of ascites that bind avb5 integrin has not yet been identified, but this is currently under investigation. It has long been established that integrins participate in cell survival, and detachment of adherent cells from their matrices induced a form of apoptosis-designated anoikis (Frisch and Ruoslahti, 1997) . Therefore, it is not surprising that avb5 integrin engagement in CaOV3 cells was associated with Akt activation and protection from TRAILinduced cell death. Further evidence supporting the function of integrin in the protection from TRAILinduced cell death in ovarian cancer cells was recently provided. In this report, detachment of ovarian cancer cells was shown to sensitize them to TRAIL (Lane et al., 2008) .
The integrin/FAK-Akt cascade is known to be an important survival pathway involved in drug resistance acting through the intrinsic or the extrinsic apoptotic pathway (Uhm et al., 1999; Damiano, 2002) . Integrin ligation has been shown to stimulate specific survival signals that counteract TRAIL-induced apoptosis in prostate carcinoma cells (Fornaro et al., 2003) . Although effector molecules involved in integrin-dependent cell , or avb5 integrin-blocking antibodies (5 mg/ml) for 30 min before adding OVC346 ascites. After 2 h, cells were lysed and lysates were subjected to immunobloting to detect total FAK and phosphorylated FAK. Densitometric quantification of phosphorylated FAK from three separate experiments normalized to total FAK.
Ascites stimulates avb5 integrin signaling D Lane et al survival have not been completely elucidated, engagement of fibronectin through a5b1 and avb1 and of vitronectin through avb3 have been associated with protection from apoptosis induced by serum withdrawal in Chinese hamster ovary cells (Zhang et al., 1995; Matter and Ruoslahti, 2001 ). We found that ascites factor(s) engage avb5 integrin in CaOV3 cells; however, we could not detect a significant effect of avb3 on the prosurvival activity of ascites despite the fact that both integrins are expressed in CaOV3 cells. The apparent discrepancy between our results and the aforementioned studies could be related to the different cell type used and the presence of different factors present in ascites. It is important to note that inhibition of the integrinsignaling cascade only partially abrogated the prosurvival activity of ascites. This observation suggests that ovarian cancer ascites may engage other survival pathways to inhibit TRAIL-induced cell death.
To identify ascites factors that engage avb5 integrins, we have assessed the effect of vitronectin and osteopotin, two proteins that may bind avb5 integrins, on TRAIL-induced cell death. However, none of these proteins affected TRAIL-induced cell death (Supplementary Figure 3 ). Other possible ligands to avb5 integrins include osteoprotegerin and periostin. Osteoprotegerin has an anti-apoptotic effect against TRAILinduced apoptosis as it may act as a soluble receptor for TRAIL. We do not believe, however, that osteoprotegerin contained in ascites directly binds to TRAIL to inhibit its effect because the prosurvival effect of ascites is almost completely abolished by the Akt inhibition (Lane et al., 2007) . Interestingly, osteoprotegerin may bind to avb5 integrin to stimulate cell migration and proliferation of endothelial cells (Kobayashi-Sakamoto et al., 2008) . Periostin is secreted by epithelial ovarian carcinoma and accumulates in ascites (Gillan et al., 2002) . Periostin binds to avb5 integrin and promotes cell motility. These two proteins may thus be implicated in mediating the prosurvival of ascites by binding to avb5 integrin and activating the Akt pathway. Work is currently underway to determine the contribution of these proteins. 
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Although the precise mechanism(s) by which Akt inhibits TRAIL-induced cell death in EOC cells has not been completely elucidated, recent data suggest a preferential involvement upstream of the initiator caspase-8 through c-FLIPs-mediated inhibition of the death-inducing-signaling complex (Lane et al., 2007) . The function of c-FLIPs is supported by the fact that ascites-mediated up-regulation of its expression was partially blocked by avb5 integrin-blocking antibodies. Evidence also exists for a function of Akt in counteracting the intrinsic, mitochondrial-dependent apoptosis cascade, and Akt may effectively block TRAIL-induced cell death through Bcl-2 or Bid in prostate or breast cancer cells (Kandasamy and Srivastava, 2002; Sivaprasad et al., 2007) . Although these findings may indicate a potential interference of Akt at the pre-mitochondrial level, it is currently unknown whether ascites signals through this pathway to inhibit TRAIL-induced apoptosis in EOC cells (Figure 9 ). However, we earlier reported that ascites did not affect the protein expression levels of Bcl-2, Bcl-XL, Bax, and Bak (Lane et al., 2007) , suggesting that these proteins may not be prime targets of Akt. Therefore, our data add to the growing body of evidence suggesting that ascites actively contributes to the development and progression of ovarian cancer by counteracting the effect of death receptor ligands such as TRAIL. In agreement with earlier studies that have shown that integrin ligation protects cells from druginduced apoptosis, our results show that the ascitesmediated integrin-Akt-signaling pathway inhibits cell death induced by death receptor ligand. Understanding the various and complex function of ascites and its influence on cancer development is essential for optimizing the current and future therapeutic approaches.
Materials and methods

EOC ascites
Ascites is obtained at the time of cytoreductive surgeries from patients with primary stage III ovarian cancer or from paracenthesis for recurrent stage III ovarian carcinoma diseases. Informed consent was obtained from all participants for this institutional review board approved protocol. All samples were supplied by the Tumor Bank of the 'Re´seau de Recherche en Cancer du Fond de Recherche en Sante´du Que´bec.' Ascites was centrifuged at 1000 r.p.m. for 10 min and supernatants were aliquoted into 1 ml samples, and stored at À80 1C until assayed. In some experiments, ascites was inactivated by heating for 15 min at 95 1C and centrifugation for 30 min at 13 000 r.p.m. Ascites was fractionated by centrifugation in an Ultrafree-15 centrifugal filter 5000 cutoff device (Millipore, Temecula, CA, USA).
Reagents TRAIL was purchased from PeproTech (Rocky Hill, NJ, USA). LPA ELISA was purchased from Echelon Bioscience Inc. (Salt Lake City, UT, USA). Growth factor receptor selective inhibitors AG825 (Her2/neu), AG1024 (IGF-R1), AG1478 (EGFR), PD153035 (EGFR), SU1498 (FGFR), SU5402 (VEGFR), and c-FLIPs antibody were obtained from EMD/Calbiochem (San Diego, CA, USA). Antibodies for Akt, FAK, and caspase-3 were from Cell Signaling. Anticaspase-8 antibodies were from R&D Systems (Minneapolis, MN, USA). HRP-conjugated anti-mouse and -rabbit antibodies were from Cell Signaling. Antibodies for phospho-Akt (Ser-473), anti-phospho-EGFR (tyr-1068), and anti-phospho-FAK (tyr-397) were from Invitrogen (Carlsbad, CA, USA). Integrin-blocking antibodies anti-avb3 (clone LM609), antiavb5 (clone PF16), anti-av (clone AV1), anti-b1 (clone 6S6), and anti-b3 (clone 25E11) were from Millipore (Temecula, CA, USA). Phenazine methosulfate and anti-tubulin antibody were obtained from Sigma (Oakville, Ontario, Canada).
Cell culture and viability assays
The human EOC cell line CaOV3 was obtained from the American Type Culture Collection (Manassas, VA, USA). CaOV3 cells were cultured in DMEM/F12 (Wisent, St-Bruno, QC, Canada) supplemented with 10% FBS, 2 mM glutamine, and antibiotics. Cell viability in the presence or absence of TRAIL was determined by XTT assay. Briefly, cells were plated at 20 000 cells/well, and the next day, cells (confluence 60-70%) were treated with TRAIL and incubated for 48 h. In some experiments, growth factor receptor inhibitors were added 30 min before the addition of ascites (10% v/v) followed 1 h later by the addition of TRAIL. At the termination of the experiment, the culture media was removed and a mixture of PBS and fresh media containing phenazine methosulfate and XTT was added for 30 min. The optical density was determined using a microplate reader at 450 nm ( Ovarian cancer Ascites factor(s)
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Apoptosis Figure 9 Schematic model for ovarian cancer ascites-mediated protection from TRAIL-induced cell death. TRAIL binding to death receptors TRAIL-R1 and TRAIL-R2 results in deathinducing-signaling complex (DISC) formation, activation of procaspase-8, Bid cleavage, release of cytochrome c from mitochondria, and caspase-9 and caspase-3 activation. Binding of ascites survival factors to avb5 integrin leads to the phosphorylation of FAK and Akt. Activation of Akt does not affect the levels of pro-apoptotic proteins Bax and Bak and anti-apoptotic proteins Bcl-2 and Bcl-XL, but up-regulates the levels of c-FLIPs proteins (Lane et al., 2007) . In turns, c-FLIPs inhibit caspase-8 activation at the DISC and decrease TRAIL-induced cell death (Lane et al., 2007) .
Ascites stimulates avb5 integrin signaling D Lane et al survival was defined as the relative optical density of untreated versus TRAIL-treated cells.
Caspase assays
Caspase-3 and caspase-8 fluorogenic protease assays were performed according to the manufacturer's protocol (R&D Systems). In brief, 3 Â 10 6 cells were lysed in 250 ml of cell lysis buffer, and total cell lysates were incubated with 50 mM of DEVD-AFC (caspase-3) or IETD-AFC (caspase-8) substrate for 1 h at 37 1C. Caspase-3 and caspase-8 activities were measured on a Versa Fluor fluorometer (Bio-Rad, Hercules, CA, USA). Protein concentration of the lysates was measured with Bio-Rad protein assay kit.
The release of nucleosomal DNA into the cytoplasm was determined using the Cell Death Detection ELISA kit (Roche, Que´bec, Canada). Briefly, cells were treated with TRAIL in the presence or absence of ascites (10% v/v) for 24 h. Cells were then lysed and the extracted cytoplasmic nucleosomal DNA was captured in ELISA wells containing anti-histone antibodies. The nucleosomal DNA was detected with an anti-DNA-POD-conjugated antibody. The absorbance of each well was determined using a microplate reader at 410 nm (TecanSunrise).
Immunoblot analysis
Cells were harvested and washed with ice-cold PBS. Whole cell extracts were prepared in lysing buffer containing protease inhibitors (0.1 mM AEBSF, 5 mg/ml pepstatin, 0.5 mg/ml leupeptin, and 2 mg/ml aprotinin), and cytosolic proteins were separated by 12% SDS-PAGE gels. Lysates for phosphorylated proteins were performed in the presence of phosphatase inhibitors (100 mM sodium fluoride, 100 mM sodium pyrophosphate, 250 mM sodium orthovanadate). All primary antibodies were incubated overnight at 4 1C. Proteins were visualized by enhanced chemiluminescence (GE Healthcare, Que´bec, Canada). Densitometric analyses were performed with the ImageJ software.
Flow cytometry for integrin expression CaOV3 cells were incubated in the presence or absence of ascites for 24 h. Cells were detached with EDTA solution, centrifuged, and rinsed with PBS. Cells were fixed for 20 min with 4% formaldehyde in PBS, then rinsed three times with PBS and kept at 4 1C until assayed. After incubation with a mouse anti-integrin antibody, cells were rinsed with PBS and incubated with PE-conjugated donkey anti-mouse antibody (Jackson ImmunoResearch, West Grove, PE, USA) for 45 min at room temperature. Cells were analyzed using an FAC-scan flow cytometer (Beckton Dickinson, Mississauga, Ontario, Canada). The isotypic mouse IgG was used as control.
Knockdown of FAK
The Fluorescein-labeled Luciferase GL2 duplex, which was used as a control, and the FAK siRNA oligonucleotides were purchased from Dharmacon Research, Inc. (Ottawa, Ontario, Canada) Cells (6 Â 10
